ARCHIVES

NIH Director Healy Resigned, To Return To Cleveland In June’ Kessler To Remain

This article is from The Cancer Letter archive.

Vol. 19 No. 10 | March 5, 1993

Download PDF Visit The Full Archive

Related Articles

FDA Commissioner Holds Up IND While Reviewing Toxicology Guidelines

August 14, 1981

Low Adiponcetin Hormone Levels Linked to Increased Cancer Risk

January 25, 2013

DCT Board Approves Three New BRMP RFAs For Immunologic Research, $1.5 Million A Year

February 27, 1987

Intramural Pis To Control Own Budgets, Have Greater Autonomy, Klausner Says

December 15, 1995

Sponsors Withdraw Indications for Iressa, Celebrex

February 11, 2011

Long-Term Results Of STAR Find Raloxifene Causes Fewer, Less Severe Side Effects

April 30, 2010